Edition:
United Kingdom

Profile: Suven Life Sciences Ltd (SUVP.NS)

SUVP.NS on National Stock Exchange of India

267.95INR
24 May 2019
Change (% chg)

Rs8.45 (+3.26%)
Prev Close
Rs259.50
Open
Rs261.90
Day's High
Rs270.50
Day's Low
Rs260.80
Volume
288,584
Avg. Vol
339,266
52-wk High
Rs337.80
52-wk Low
Rs182.70

Suven Life Sciences Limited is a bio-pharmaceutical company. The Company is engaged in the business of manufacture and sale of bulk drugs and intermediaries. The Company's segments include Manufacturing (CRAMS), which develops and produces bulk drugs and intermediates under contract manufacturing services; Services (DDDSS), which consists of collaborative research projects (CRP), clinical trials, and testing and analysis services, and Research and Development. Its products consist of active pharmaceutical ingredients (APIs), including Aripiprazole, Armodafinil, Calcium Acetate, Carprofen, Deferasirox, Doxofylline, Entacapone, Fenoprofen Calcium, Rosuvastatin Calcium, Sitagliptin Phosphate and Solifenacin succinate, and intermediates, including 2-nitro phenyl acetic acid and 3,4-dichlorobenzylamine. The Company is engaged in the drug discovery specializing in central nervous system (CNS)-based programs with over four of the molecules in pipeline under clinical phase of development.

Company Address

Suven Life Sciences Ltd

SDE Serene Chambers 6th Floor
Road No. 5 Avenue 7, Banjara Hil
HYDERABAD     500034
P: +9140.23541142
F: +9140.23541152

Company Web Links